Pauly M, Kayser I, Schmitz M, Ries F, Hentges F, Dicato M
Laboratoire de Recherche sur le Cancer et les Maladies du Sang, Centre Universitaire de Luxembourg, Grand-Duchy of Luxembourg.
J Mol Evol. 1995 Dec;41(6):974-8. doi: 10.1007/BF00173178.
The mdr1 gene, first member of the human multidrug-resistance gene family, is a major gene involved in cellular resistance to several drugs used in anticancer chemotherapy. Its product, the drug-excreting P-glycoprotein, shows a bipartite structure formed by two similar adjacent halves. According to one hypothesis, the fusion of two related ancestral genes during evolution could have resulted in this structure. The DNA sequence analysis of the introns located in the region connecting the two halves of the human mdr1 gene revealed a highly conserved poly(CA).poly (TG) sequence in intron 15 and repeated sequences of the Alu family in introns 14 and 17. These repeated sequences most likely represent "molecular fossils" of ancient DNA elements which were involved in such a recombination event.
mdr1基因是人类多药耐药基因家族的首个成员,是参与细胞对几种用于抗癌化疗药物耐药性的主要基因。其产物,即药物排泄性P-糖蛋白,呈现出由两个相似相邻部分形成的二分结构。根据一种假说,进化过程中两个相关祖先基因的融合可能导致了这种结构。对位于人类mdr1基因两半连接区域的内含子进行的DNA序列分析显示,内含子15中有一个高度保守的聚(CA)·聚(TG)序列,内含子14和17中有Alu家族的重复序列。这些重复序列很可能代表了参与此类重组事件的古代DNA元件的“分子化石”。